Aurobindo Pharma share news, announcements and annual reports

NSE: AUROPHARMABSE: 524804Pharmaceuticals & BiotechnologyMid Cap

Aurobindo Pharma Limited · Face value ₹1 · Listed Apr 1995 on BSE, Jul 2000 on NSE

₹1,681.40₹21.50 (1.30%)BSE ₹1,677.80

Share price at the NSE close on 30 Oct 2026. Previous close ₹1,659.90.

30 Oct: open ₹1,652.00, high ₹1,687.00, low ₹1,647.20

52-week range of traded prices to 30 Oct 2026

₹1,091.20Low, 30 Oct 2025₹1,740.00High, 24 Sep 2026

Next results date: the board meets on 4 Nov 2026 to consider: financial results and dividend. The notice · Results calendar

Market cap: ₹96,744 Cr138th largest listed
P/E: 26.06
P/B: 2.55
Dividend yield: Nonein the last 12 months
ROE: 10.5%
ROCE: 11.5%
Debt to equity: 0.20
Volume, NSE: 9,52,65057.5% delivered

Aurobindo Pharma shareholding disclosures

160 filed, newest first. Page 2 of 4.

Mar 2014
- 10 Mar · Disclosure
  Vide letter dated March 07, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.
Jan 2014
Nov 2013
- 21 Nov · Disclosure
  Vide letter dated November 21, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.
- 20 Nov · Disclosure
  Vide letter dated November 20, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.
Aug 2013
- 12 Aug · Disclosure
  Compensation Committee of the Board at the meeting held on August 09, 2013, has considered and approved grant of 30,000 options at an exercise price of Rs. 161.30 per option (each option confer a right to one equity share of Re. 1/- each) under the Employees Stock Option Plan, 2006.
Jun 2013
- 10 Jun · Disclosure
  Vide letter dated June 07, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with Disclosure under Regulation 13(3) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.
May 2013
- 27 May · Disclosure
  Vide letter dated May 23, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
- 27 May · Disclosure
  P. Suneela Rani has submitted to the Exchange vide letter dated May 17, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Apr 2013
- 2 Apr · Disclosure
  Vide letter dated March 30, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
- 1 Apr · Disclosure
  K. Nithyananda Reddy has submitted to the Exchange, vide letter dated March 29, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Mar 2013
Feb 2013
Jan 2013
- 30 Jan · Disclosure
  P. Suneela Rani has submitted to the Exchange vide letter dated January 29, 2013 a copy of disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
- 30 Jan · Disclosure
  Vide letter dated January 25, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.
- 29 Jan · Disclosure
  Vide its letter dated January 25, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.
- 28 Jan · Disclosure
  Compensation Committee of the Board on January 28, 2013, has considered and approved grant of 9,15,500 options at an exercise price of Rs. 187.40 per option (each option confer a right to one equity share of Re. 1/- each) under the Employees Stock Option Plan, 2006.
- 24 Jan · Disclosure
  P. Suneela Rani has submitted to the Exchange vide letter dated January 23, 2013 a copy of disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
- 24 Jan · Disclosure
  Vide letter dated January 23, 2013 a copy of disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
- 21 Jan · Disclosure
  Vide letter dated January 19, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.
- 21 Jan · Disclosure
  M. Sumanth Kumar Reddy has submitted to the Exchange vide letter dated January 19, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.
- 16 Jan · Disclosure
  Vide letter dated January 16, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
- 9 Jan · Disclosure
  Compensation Committee of the Board at its meeting held on January 09, 2013, has considered and approved grant of 5,00,000 options at an exercise price of Rs.200.70 per option (each option confer a right to one equity share of Re.1/- each) under the Employees Stock Option Plan, 2006.
Dec 2012
Nov 2012
- 27 Nov · Disclosure
  P. Suneela Rani has submitted to the Exchange vide letter dated November 26, 2012 a copy of disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Oct 2012
- 4 Oct · Disclosure
  Vide letter dated October 04, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
- 4 Oct · Disclosure
  P. Suneela Rani has submitted to the Exchange vide its letter dated October 04, 2012 a copy of disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Sep 2012
- 6 Sep · Disclosure
  Vide letter dated September 05, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Aug 2012
Jul 2012

Aurobindo Pharma shareholding disclosures

Mar 2014

Jan 2014

Nov 2013

Aug 2013

Jun 2013

May 2013

Apr 2013

Mar 2013

Feb 2013

Jan 2013

Dec 2012

Nov 2012

Oct 2012

Sep 2012

Aug 2012

Jul 2012